PARP Inhibitors Targeted Therapy in Dehradun
PARP Inhibitors Targeted Therapy in Dehradun
PARP inhibitors are a type of targeted cancer therapy used to treat certain gynecologic cancers, particularly ovarian cancer. These medications work by blocking a protein called PARP (Poly ADP-Ribose Polymerase) that helps cancer cells repair damaged DNA.
When PARP is blocked, cancer cells are unable to repair themselves properly and eventually die. This targeted approach helps destroy cancer cells while minimizing damage to normal healthy cells.
PARP inhibitors are especially effective for patients who have BRCA1 or BRCA2 gene mutations.
How Do PARP Inhibitors Work?
PARP inhibitors interfere with DNA repair mechanisms inside cancer cells. Their action can be understood in three steps:
DNA Damage Occurs
Cells experience DNA damage as part of normal biological processes and through cancer-related changes.
PARP Activity Is Blocked
PARP inhibitors prevent PARP proteins from carrying out their normal DNA repair functions and can trap PARP on damaged DNA.
Cancer Cells Become Unable to Repair Damage
In certain cancer cells with impaired alternative DNA repair pathways, the accumulated damage can lead to cell death.
How Do These Tests Help?
How Is PARP Inhibitor Treatment Given?
Cancer Evaluation
The specialist reviews the diagnosis, pathology reports, imaging, stage of cancer and previous treatment history.
Genetic and Tumour Testing
BRCA testing and, when appropriate, HRD testing may be recommended to assess the molecular characteristics of the cancer.
Treatment Planning
The specialist determines whether a PARP inhibitor is an appropriate option and discusses its potential benefits, risks and alternatives.
Starting Treatment
The If recommended, the medicine is prescribed with instructions regarding dosage, timing and duration.
Potential Benefits of PARP Inhibitor Targeted Therapy
Possible Side Effects of PARP Inhibitors
Frequently Asked Questions About PARP Inhibitors
Laparoscopic surgery is a minimally invasive surgical technique that uses small incisions and a thin camera called a laparoscope to perform procedures inside the abdomen or pelvis. It allows surgeons to treat various gynecologic conditions with greater precision and less trauma compared to traditional open surgery.
Selected patients with relevant BRCA1 or BRCA2 mutations or HRD-positive tumours may be eligible. Previous response to platinum-based chemotherapy and other clinical factors are also considered.cancers such as ovarian and endometrial cancer.
BRCA testing is an important part of treatment assessment. Depending on the cancer type and treatment setting, HRD testing may also be recommended.
Most commonly used PARP inhibitors are taken orally as tablets or capsules. The medicine, dosage and duration are determined by the treating oncologist.
Treatment duration depends on the prescribed medicine, cancer type, treatment setting, response and side effects. The treating specialist determines how long therapy should continue.